Geoff Saunders retirement announcement

Geoff qualified as a Pharmacist in 1982 and has held a variety of NHS roles as an oncology pharmacist since then. His current role of Consultant Oncology Pharmacist at the Christie Hospital in Manchester combines clinical practice, leadership, education and research & evaluation. As an independent prescriber he works alongside colleagues in the Gynae medical oncology clinics facilitating the prescription of chemotherapy and supportive medication. Geoff was chair of BOPA from 2007 to 2009 and has had a positive influence on many pharmacists over the years with his strong leadership and clinical skills.

 

BOPA wishes former chair and BOPA fellow Geoff Saunders a very happy retirement!

Take Care Geoff, Oncology Pharmacy will miss you!

Latest News

By UK SACT Protocols Pilot Team on 20th November 2026

Have Your Say: Review the First UK SACT Protocol and Provide Feedback

Dear Colleagues working in cancer services We are writing to invite you to review and provide feedback on the first protocol produced as part of the UK SACT Protocols Pilot.…

Read article
By Mohammed Patel on 11th November 2026

UK BMT Pharmacists Group Educational Meeting – Friday 13th November 2026. Time:14:00 to 16:00

The next UK BMT Pharmacists Group Educational Meeting is on Friday 13th November, 2pm–4pm. The sessions include: Maintenance Therapy for AML After Allogeneic BMT with Dr Mili Shah, Consultant Haematologist,…

Read article
By UK SACT Board on 9th November 2026

New UK SACT Board National Intrathecal and Intraventricular SACT Guidance

Dear colleagues, We are pleased to share the newly published UK SACT Board National Guidance on the Safe Administration of Systemic Anti-Cancer Therapies via the Intrathecal or Intraventricular Routes. This…

Read article
By BOPA Executive Committee on 9th November 2026

BOPA members flying the flag for cancer pharmacy at ESMO 2026

It was fantastic to see BOPA members representing cancer pharmacy at ESMO Congress 2026 in Madrid, which brought together the global cancer community from 23 to 27 October to share…

Read article